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ABSTRACT 
 
Diabetes mellitus is a major cause of morbidity and mortality and is the leading cause of  
 
end-stage renal disease worldwide. New onset diabetes post renal transplantation is  
 
associated with reduced graft function, decreased patient survival and increased risk of  
 
graft loss. The immunosuppressive regimes used and dosage of corticosteroid therapy  
 
appear to impact on the incidence of new onset diabetes post renal transplantation. 
 
 
The objectives of this study were: to ascertain the prevalence of new onset diabetes post 
 
transplantation; to determine the association between new onset diabetes with  
 
immunosuppressive regimens and ethnicity; and to assess outcomes in terms of morbidity  
 
and mortality. 
 
 
The study design consisted of a retrospective analysis of 398 patient files transplanted  
 
between 01/07/1994 and 30/06/2004. Information retrieved from the files consisted of  
 
patient demographics ( age, race, gender ), weight, date of onset of diabetes,  
 
immunosuppressive regimens used, infections, cardiovascular and overall morbidity and  
 
mortality. The diagnosis of diabetes was based on the American Diabetes Association  
 
(ADA) criteria or the requirement for anti-diabetic agents. 
 
 
Results obtained showed that 15.58% (62/398) of patients became diabetic. The mean  
 
time to onset of diabetes was 22.9 months ( range 1 week to 100 months ). 20.21% Black  
 
patients (p=0.100), 9.42% White, 12.5% Coloured and 12% Indian patients became  
 
diabetic. Treatment with Cyclosporine( CyA) had an incidence of diabetes of 14.44%,  
 
Tacrolimus 20.25% p = 0.228, Rapamune 11.36% and Mycophenolate Mofetil 11.97%.  
 
 
Infections occurred in 96.77% of diabetic patients, p = <0.0001. Cardiovascular  
 
morbidity and mortality was 11.29%, p = 0.82. Overall mortality was 79.3% in the  
 
diabetic group p = 0.237, HR 1.45. 
 
 
In conclusion, the incidence of new onset diabetes is significant as it confers a higher risk  
 
of infections and overall mortality. Black patients are more affected, with an increased  
 
risk for those treated with Tacrolimus. 
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